Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

VMY-2-109 treatment leads to reduction in nicotine self-administration in vivo

Nov. 27, 2013

SUVN-A60203 and its effects on alcohol consumption

Nov. 21, 2013

BARDA exercises option for continued development of AverTox against nerve agents

Nov. 18, 2013

Otsuka and Lundbeck partner for nalmefene in Japan

Nov. 5, 2013

AEOL-10150 improves survival in mice exposed to lethal radiation

Oct. 31, 2013

FDA accepts filing for Bunavail NDA

Oct. 10, 2013

FDA grants Titan Pharmaceuticals meeting regarding Probuphine NDA

Sep. 30, 2013

BARDA exercises additional funding to develop Aeolus's drug for acute radiation syndrome

Sep. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...